SWOG clinical trial number
SWOG-8239

Evaluation of Spirogermanium (NSC-192965) in Central Nervous System Tumors

Closed
Phase
Published
Abbreviated Title
Evaluation of Spirogermanium (NSC-192965) in Central Nervous System Tumors
Activated
01/31/1983

Publication Information Expand/Collapse

1987

Phase II trial of spirogermanium in central nervous systemtumors: A Southwest Oncology Group Study.

JW Goodwin;J Crowley;B Tranum;R Vance;M Slavik;S Balcerzak;D Hacker Cancer Treat Rep 71(1):99-100

1985

A Phase II study of spirogermanium in central nervous system tumors: A Southwest Oncology Group study.

W Goodwin;B Tranum;W Slavik;R Vance ASCO, #C-517

1984

Phase II clinical trial of spirogermanium in central nervous system tumors: A Southwest Oncology Group study.

M Slavik;W Goodwin;B Tranum;R Vance 3rd European Conference on Clinical Oncology and Cancer Nursing